Marcelo Bellesso

How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation

Guilherme Fleury Perini, Thaís Fischer, Rafael Dezen Gaiolla et al. · Hematology Transfusion and Cell Therapy · 2020 · 37 citations · Full text

Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates – A multicenter cohort study

Wellington Fernandes da Silva, Pedro Manoel Marques Garibaldi, Lidiane Inês da Rosa et al. · Leukemia Research · 2019 · 21 citations

Treatment And Prevention, Clinical Epidemiology, Refractoriness Rates +6

Health care-associated infections in hematology-oncology patients with neutropenia: A method of surveillance

Karim Yaqub Ibrahim, Lı́gia Camera Pierrotti, Maristela Pinheiro Freire et al. · American Journal of Infection Control · 2013 · 19 citations · Full text

Healthcare-associated Infection, Patient Safety, Hematology +6

Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene

Marcelo Bellesso, Rodrigo Santucci, Daniela Ferreira Dias et al. · Revista Brasileira de Hematologia e Hemoterapia · 2013 · 18 citations · Full text

Second COVID-19 infection in a patient with multiple myeloma in Brazil – reinfection or reactivation?

Marcelo Bellesso, Felipe Ribeiro Bruniera, Ariel Testasicca Trunkel et al. · Hematology Transfusion and Cell Therapy · 2020 · 14 citations · Full text

Second Covid-19 Infection, Viral Persistence, Brazil – Reinfection +9